Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 20 10:44AM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.50 Insider Own7.38% Shs Outstand0.94M Perf Week3.30%
Market Cap3.38M Forward P/E- EPS next Y-3.33 Insider Trans0.00% Shs Float0.87M Perf Month-5.51%
Income-7.18M PEG- EPS next Q-1.05 Inst Own1.99% Short Float5.69% Perf Quarter-69.70%
Sales0.00M P/S- EPS this Y- Inst Trans- Short Ratio0.82 Perf Half Y-67.89%
Book/sh4.81 P/B0.75 EPS next Y- ROA-122.16% Short Interest0.05M Perf Year-95.86%
Cash/sh3.39 P/C1.06 EPS next 5Y- ROE-1037.72% 52W Range3.25 - 93.75 Perf YTD-70.19%
Dividend Est.- P/FCF- EPS past 5Y50.07% ROI-253.21% 52W High-96.16% Beta-0.19
Dividend TTM- Quick Ratio2.34 Sales past 5Y0.00% Gross Margin- 52W Low10.77% ATR (14)0.40
Dividend Ex-Date- Current Ratio2.34 EPS Y/Y TTM70.74% Oper. Margin0.00% RSI (14)38.76 Volatility9.25% 8.28%
Employees3 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price12.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-470.23% Payout- Rel Volume1.02 Prev Close3.63
Sales Surprise- EPS Surprise-71.11% Sales Q/Q- EarningsMay 15 BMO Avg Volume60.21K Price3.60
SMA20-0.23% SMA50-34.29% SMA200-80.14% Trades Volume14,590 Change-0.83%
Today 08:30AM
May-16-24 08:30AM
May-15-24 09:55PM
Apr-29-24 08:00AM
07:30AM Loading…
Apr-24-24 07:30AM
Mar-25-24 08:30AM
Mar-19-24 06:53AM
Mar-18-24 04:05PM
Mar-15-24 08:15AM
Mar-11-24 08:00AM
Feb-22-24 08:30AM
Jan-16-24 08:40AM
Jan-11-24 08:00AM
Jan-05-24 09:15AM
08:30AM Loading…
Jan-04-24 08:30AM
Jan-02-24 08:30AM
Dec-01-23 08:30AM
Nov-29-23 08:05AM
Nov-13-23 04:05PM
Nov-02-23 03:00PM
Oct-31-23 09:15AM
Sep-05-23 08:30AM
Aug-14-23 04:01PM
Aug-10-23 04:15PM
Aug-01-23 08:30AM
Jul-27-23 08:30AM
Jul-25-23 08:30AM
May-15-23 04:01PM
May-12-23 08:30AM
08:30AM Loading…
Apr-27-23 08:30AM
Apr-17-23 04:01PM
Mar-30-23 04:10PM
Mar-08-23 04:01PM
Mar-02-23 08:00AM
Jan-31-23 01:30PM
Jan-27-23 11:58AM
Nov-10-22 04:10PM
Nov-08-22 12:26PM
Oct-12-22 10:25AM
Oct-11-22 02:15PM
Oct-06-22 11:00PM
Oct-03-22 08:00AM
Sep-23-22 08:51AM
Sep-22-22 04:25PM
Mar-31-22 07:30AM
Feb-16-22 08:20AM
Feb-15-22 10:00PM
Dec-15-21 02:15PM
Dec-12-21 08:00PM
Nov-29-21 08:00AM
Nov-17-21 09:30AM
Nov-12-21 10:40AM
Nov-09-21 09:30PM
Oct-25-21 07:00AM
Aug-26-21 11:04AM
Jun-21-21 08:04AM
Jun-14-21 08:42AM
Apr-26-21 08:09AM
Apr-23-21 11:36PM
Apr-22-21 10:59AM
Apr-21-21 10:34PM
Apr-19-21 10:09PM
Apr-16-21 11:25PM
Apr-14-21 10:34PM
Apr-13-21 11:30PM
Apr-12-21 01:36AM
Jan-11-21 11:32PM
Jan-06-21 09:23AM
Dec-18-20 08:00AM
Dec-17-20 04:27PM
Nov-13-20 05:28AM
Oct-28-20 07:45PM
Oct-23-20 10:00PM
Oct-14-20 08:58PM
Oct-13-20 01:29PM
Oct-12-20 01:35PM
Sep-09-20 08:00AM
Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in Bay Harbor Islands, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Davidow Robert L10% OwnerDec 11 '23Sale0.14353,00049,60022,000Dec 13 04:02 PM
Davidow Robert L10% OwnerDec 11 '23Sale0.14264,00036,960681,000Dec 13 04:02 PM
Fortress Biotech, Inc.10% OwnerSep 08 '23Buy0.72418,410301,2551,032,390Sep 12 09:02 AM
ROSENWALD LINDSAY A MDDirectorSep 08 '23Buy0.72348,675251,046354,318Sep 12 09:03 AM